Detalhe da pesquisa
1.
Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study.
Eur J Clin Microbiol Infect Dis
; 41(7): 1065-1076, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35727429
2.
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments.
J Clin Invest
; 133(6)2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727404
3.
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort.
Clin Microbiol Infect
; 29(8): 1084.e1-1084.e7, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37150358
4.
Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study.
Biomedicines
; 10(9)2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36140162
5.
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.
Front Immunol
; 13: 1062136, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36618384
6.
Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma.
J Exp Med
; 218(9)2021 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34287642
7.
Blood Cytokine Analysis Suggests That SARS-CoV-2 Infection Results in a Sustained Tumour Promoting Environment in Cancer Patients.
Cancers (Basel)
; 13(22)2021 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830872